跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEGVAL™ Powder for Solution for Injection 50mg/vial - HSA Drug Approval Details
Approvals
/
HSA
/
MEGVAL™ Powder for Solution for Injection 50mg/vial
Approved
THERAPEUTIC
MEGVAL™ Powder for Solution for Injection 50mg/vial
Emcure Pharmaceuticals Limited (INDIA)Emcure Pharmaceuticals Limited (Diluent) (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 10, 2026
Approval ID
62b0234c92b78ff5
Company
Emcure Pharmaceuticals Limited (INDIA)Emcure Pharmaceuticals Limited (Diluent) (INDIA)
Type
Therapeutic
Approval Details
Approval Id
62b0234c92b78ff5
Drug Name
MEGVAL™ Powder for Solution for Injection 50mg/vial
Product Name
MEGVAL™ Powder for Solution for Injection 50mg/vial
Approval Number
SIN17483P
Approval Date
2026-03-10
Registrant
ADVAGEN PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 10, 2026
Approval ID
62b0234c92b78ff5
Type
Therapeutic
Back to HSA Approvals
